Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors

Aromatase inhibitors (AIs) are the standard of care for postmenopausal women with estrogen receptor-positive breast cancer. Here, we performed a meta-analysis to evaluate the occurrence of menopausal symptoms in breast cancer patients receiving the AI therapy. Patients treated with AIs had an increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Dongsheng, Bi, Ling, Zhou, Jun, Tong, Yinghui, Zhao, Qingwei, Chen, Jing, Lu, Xiaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522209/
https://www.ncbi.nlm.nih.gov/pubmed/28489562
http://dx.doi.org/10.18632/oncotarget.17194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522209/
https://www.ncbi.nlm.nih.gov/pubmed/28489562
http://dx.doi.org/10.18632/oncotarget.17194

Ejemplares similares